: iStockAnalyst.com Symbols Feed

Earnings Preview for Feb 9-13 - Earnings Preview

Fri, 06 Feb 2009 18:52:00 GMT

Activision Blizzard Inc. (ATVI) could top expectations. IntercontinentalExchange, Inc. (ICE) and Terex Corporation (TEX) could miss. Though nearly 400 companies are scheduled to report, traders are going to keep a close eye on Washington. Treasury Secretary Timothy Geithner will announce a revised bank bailout plan on Monday. This plan could include the creation of a bad bank to absorb distressed debts (what TARP was[More...]

Hercules Tech: High Returns From Biotech

Thu, 23 Oct 2008 22:09:00 GMT

"With merger and acquisition activity heating up, biotech is one of the few corners of the market that's looking healthy," says Carla Pasternak. In her High Yield Investing, she adds, “As a company that invests in biotech start-ups, Hercules Technology Growth Capital (NASDAQ: [More...]

Analyst Comments: Priceline, Acergy, Toyota, RC2 Corp, Hercules Capital, AGCO

Wed, 16 Jul 2008 19:45:00 GMT

We are upgrading Priceline.com's (PCLN) shares from Hold to Buy. The strength in Priceline.com's international business and operating expense controls continue to produce impressive operating leverage. For some time, Priceline.com has been producing growt[More...]

Analyst Comments: Hercules, MIPS Technologies, EOG Resources, Famous Dave's

Wed, 23 Apr 2008 23:12:01 GMT

Hercules Technology Growth Capital Inc. (HTGC) is scheduled to report its 1Q08 financial results after market close on May 8, 2008, with a conference call scheduled later the same day. HTGC currently trades at 8.1x the consensus forward estimate (versus 9.2x at the time of our last report), a 16% discount to the peer group median (versus a 7% discount at that time). Over time, we believe that HTGC's prospective cash yield...[More...]

Labopharm Reports Results for Second Quarter Fiscal 2009

Fri, 07 Aug 2009 11:48:00 GMT

Quarter Marked by Launch of RYZOLT(TM) in U.S. -
LAVAL, QC, Aug. 7 /CNW/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its financial results for the second quarter ended June 30, 2009.
"The second quarter of 2009 was highlighted by the U.S. commercial launch of RYZOLT(TM) by our marketing partner, Purdue Pharma," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We are encouraged by a number of aspects since the launch, including the growth of new prescriptions and the migration of patients to higher dosage strengths, which shows the product is being used as intended.

: iStockAnalyst.com Symbols Feed

Earnings Preview for Feb 9-13 - Earnings Preview

Hercules Tech: High Returns From Biotech

Analyst Comments: Priceline, Acergy, Toyota, RC2 Corp, Hercules Capital, AGCO

Analyst Comments: Hercules, MIPS Technologies, EOG Resources, Famous Dave's

Labopharm Reports Results for Second Quarter Fiscal 2009

Hercules Technology Growth Capital Commits $5.5 Million to Labcyte, Inc., Developer of Acoustic Droplet Ejection Technology

Hercules to Announce Third Quarter 2009 Financial Results

Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones

Hercules Technology Growth Capital Announces a Cash Dividend of $0.30 Per Share

Hercules Technology Growth Capital to Participate in the 2009 Financial Institutions Conference Hosted By RBC Capital Markets in Boston, Massachusetts

Hercules Technology Growth Capital Receives SBA Approval to Complete Its Second SBIC License

Hercules Technology Growth Capital Announces a Cash Dividend of $0.30 Per Share

Hercules Technology Announces Second Quarter 2009 Financial Results and Declares a $0.30 Cash Dividend

Hercules Technology Growth Capital Announces Successful Fund Raising Activities From Select Life Sciences Portfolio Companies Despite Challenging Economy

Hercules to Announce Second Quarter 2009 Financial Results and Quarterly Dividend

Form 4 HERCULES TECHNOLOGY GROW For: Nov 23 Filed by: Shah Parag (10K)

Form 4 BADAVAS ROBERT P For: Sep 30 (10K)

Form 4 Shah Parag For: Sep 23 (10K)

Form 4 WOODWARD ALLYN C JR For: Sep 01 (10K)

Form 4 BADAVAS ROBERT P For: Jun 30 (10K)

Form 4 WOODWARD ALLYN C JR For: Jun 03 (10K)

Form 4 BADAVAS ROBERT P For: Mar 31 (10K)

Form 4 Shah Parag For: Mar 17 (10K)

Form 4 Lund David Michael For: Mar 17 (10K)

Form 4 Harvey H Scott For: Mar 17 (10K)